Company intelligence / Profile preview

苏州海特比奥

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

HitBio is a biotechnology company specializing in DNA-encoded library (DEL) technology for small molecule drug discovery. The company provides high-throughput screening services and collaborative drug discovery platforms to pharmaceutical and biotech partners globally. Beyond its service offerings, HitBio maintains an internal pipeline focused on oncology and other therapeutic areas. Its platform enables the rapid identification of novel chemical leads against challenging biological targets. The company was founded by experts in the DEL field and is headquartered in Suzhou, China.

Therapeutic areas: OncologyImmunology
Modalities: Small molecule
Industry: Biotech

Partnerships

Undisclosed pharmaceutical partners

Beyond the preview

Go deeper on 苏州海特比奥.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 苏州海特比奥.

Explore the full profile